logo

For the Inventor, By the Inventor

Sewell, NJ, United States of America

Chester Sapino

This inventor holds 6 USPTO granted patents. Top assignee: Johnson Matthey Public Limited Company. Active years: 1998-2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chester Sapino. Retrieved from https://idiyas.com/inventor/chester-sapino

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6

% Patents Active = 100.0

Average Co-Inventor Count = 2.3

ph-index = 4

Forward Citations = 114(Granted Patents)


Company Filing History:

goldMedal6 out of 854 
 
Johnson Matthey Public Limited Company
 patents

Years Active: 1998-2002

Loading Chart...
6 patents (USPTO):Explore Patents
1. 6365742 - Preparation of opiates, intermediates and uses of salts (2002-04-02),
2. 6096923 - Process for the preparation of nitrosourea compounds (2000-08-01),
3. 6096760 - Solid .alpha.-phenyl-2-piperidine acetate free base, its preparation and (2000-08-01),
4. 6090943 - Preparation of opiates, intermediates and uses of salts (2000-07-18),
5. 5981751 - Method for removal of residual organic solvents and use thereof in (1999-11-09),
6. 5847142 - Preparation of narcotic analgesics (1998-12-08),

Title: Chester Sapino: Innovator in Pharmaceutical Chemistry

Introduction

Chester Sapino is a notable inventor based in Sewell, NJ (US), recognized for his contributions to pharmaceutical chemistry. He holds a total of 6 patents, showcasing his innovative work in the field.

Latest Patents

Among his latest patents is a significant process for the preparation of opiates, specifically focusing on the preparation of thebaine and its salts, such as the bitartrate. This patent also introduces a novel intermediate that is useful in the preparation of oxycodone and analogous 14-hydroxymorphinones. Another important patent involves the disclosure of methyl .alpha.-phenyl-2-piperidine acetate (free base) as a crystalline solid, along with a method for its preparation. This compound is particularly noted for its use in medicine as a stimulant for the central nervous system, including pharmaceutical formulations like transdermal patches.

Career Highlights

Chester Sapino is currently employed at Johnson Matthey Public Limited Company, where he continues to advance his research and development efforts in pharmaceutical applications. His work has significantly impacted the field, particularly in the synthesis of important medicinal compounds.

Collaborations

Chester has collaborated with notable coworkers, including Bogdan Mudryk and Jen-Sen Dung, contributing to various innovative projects within the company.

Conclusion

Chester Sapino's work exemplifies the spirit of innovation in pharmaceutical chemistry, with his patents paving the way for advancements in medical treatments. His contributions are invaluable to the industry and continue to influence future developments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…